PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.\', \'Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, United Kingdom.\', \'Department of Endocrinology, Leeds Medical School, Leeds, United Kingdom.\', \'Department of Research, Royal College of Surgeons in Ireland Bahrain, Adliya, Bahrain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fendo.2021.665134
?:doi
?:hasPublicationType
?:journal
  • Frontiers in endocrinology
is ?:pmid of
?:pmid
?:pmid
  • 34248841
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.79
?:rankingScore_hIndex
  • 42
is ?:relation_isRelatedTo_publication of
?:title
  • Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection?
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34248841>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34248841>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all